EC approves new easy-to-use, once-weekly Bydureon BCise device for patients with type-2 diabetes
AstraZeneca announced that the EC has approved Bydureon BCise as a new formulation within the marketing authorisation for Bydureon for the treatment of patients...
Exact Sciences and Pfizer Enter into U.S. Promotion Agreement for Cologuard®
Exact Sciences Corp and Pfizer Inc. announced an agreement through 2021 to co-promote Cologuard, the first and only FDA-approved non-invasive stool DNA screening test...
U.S. FDA approves opdivo as the first new medication in nearly 20 years for certain patients with previously treated small cell lung cancer
Bristol-Myers Squibb Company announced that Opdivo (nivolumab) received approval from the U.S. FDA as the first and only Immuno-Oncology treatment option for patients with...
Eisai And Merck announce FDA approval of LENVIMA capsules for first-line treatment of Unresectable Hepatocellular Carcinoma
Eisai Inc. and Merck , known as MSD outside of the United States and Canada , announced that the U.S. FDA approved the kinase...
FDA approves first generic version of EpiPen
The U.S. FDA approved the first generic version of EpiPen and EpiPen Jr (epinephrine) auto-injector for the emergency treatment of allergic reactions, including those...
FDA approves new treatment for a rare genetic disorder, Fabry disease
The U.S. FDA approved Galafold (migalastat), the first oral medication for the treatment of adults with Fabry disease. The drug is indicated for adults...
The EU approves Tagrisso for 1st-line treatment of EGFR-mutated non-small cell lung cancer
The European Commission has granted marketing authorisation for Tagrisso (osimertinib) as monotherapy for the 1st-line treatment of adult patients with locally-advanced or metastatic non-small...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...